Form 4: Sera Prognostics Chief Scientific Officer Boniface Sells Shares to Cover Tax Obligations

John J. Boniface, Chief Scientific Officer of Sera Prognostics, sold 5,132 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 8, 2025, John J. Boniface, the Chief Scientific Officer of Sera Prognostics, sold 5,132 shares of Class A Common Stock.
• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The sale was mandated by Sera Prognostics' policy requiring 'sell to cover' transactions for tax obligations.
• The shares were sold at a weighted average price of $2.44, with individual transactions ranging from $2.10 to $2.78.
• Following the transaction, Boniface directly owns 165,718 shares of Sera Prognostics.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.

Industry Context

This is a routine Form 4 filing related to an executive's stock sale to cover tax obligations, a common practice in publicly traded companies.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

SERA, Sera Prognostics, John J. Boniface, Chief Scientific Officer, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership